APR 12, 2021 11:14 AM PDT

Chronic Pain Patients Can Find Long-Term Success Using Cannabis

WRITTEN BY: Angela Dowden

Many users report immediate pain relief from using medical cannabis, but now a recently published study suggests chronic pain patients can find longer-term success using the drug.

The research by Cognitive and Clinical Neuroimaging Core collaborators at Harvard Medical School and McLean Hospital in Boston, was published in Experimental and Clinical Psychopharmacology. It observed 37 patients with chronic pain who were evaluated prior to initiation of medicinal cannabis treatment and then 3 and 6 months down the road.

Analyses of the patients, many of whom had musculoskeletal pain or neuropathy, included their pain levels, clinical state, sleep, quality of life, and conventional medication use. It found a sustained improvement in the participants’ symptoms.

“Relative to baseline, following 3 and 6 months of treatment, MC patients exhibited improvements in pain which were accompanied by improved sleep, mood, anxiety, and quality of life, and stable conventional medication use,” the researchers wrote.“Reduced pain was associated with improvements in aspects of mood and anxiety.”

The authors also found that many subjects reduced their use of opioids over the trial period, though not to a degree that reached statistical significance. They concluded, “[These] findings are promising, as they underscore previous survey studies also reporting the reduced use of conventional medications, specifically opioids, following the initiation of MC treatment.”

Alongside this study, the researchers also studied a pilot group of nine patients with similar chronic pain conditions who did not use medical cannabis to treat their symptoms during the study period. Data from those patients “did not reveal a similar pattern of improvement as the medical cannabis patients on measures of pain or clinical measures between baseline and follow-up,” the researcher wrote.

Interestingly, the research also found different effects of different cannabinoids, with the results suggesting increased THC exposure was related to pain-related improvement, while increased CBD exposure was related to improved mood.

“[These] findings highlight the potential efficacy of MC treatment for pain and underscore the unique impact of individual cannabinoids on specific aspects of pain and comorbid symptoms,” the researchers concluded.

Sources: High Times, NORML, Pub Med

 

About the Author
  • I'm a journalist and author with many year's experience of writing for both a consumer and professional audience, mostly on nutrition, health and medical prescribing. My background is food science and I'm a registered nutritionist.
You May Also Like
APR 10, 2021
Cannabis Sciences
Cannabis Users Exercise More than Nonusers
APR 10, 2021
Cannabis Users Exercise More than Nonusers
The rate of cannabis use among American adults tripled between 2003 and 2018 from 4.1% to 15.9%. During this time, some ...
APR 14, 2021
Cannabis Sciences
Medicinal Cannabis Content Labels are Inaccurate, Study Finds
APR 14, 2021
Medicinal Cannabis Content Labels are Inaccurate, Study Finds
Researchers from Massachusetts General Hospital (MGH) have found that content labels on medicinal cannabis products are ...
APR 18, 2021
Genetics & Genomics
The Biology of Autism May Depend on Sex
APR 18, 2021
The Biology of Autism May Depend on Sex
It's been unclear whether boys are diagnosed with autism spectrum disorder more often because of detection issues, or if ...
APR 27, 2021
Cannabis Sciences
CBD Doesn't Reduce Pain, but Makes it Less Unpleasant
APR 27, 2021
CBD Doesn't Reduce Pain, but Makes it Less Unpleasant
While anecdotal reports tout cannabidiol’s (CBD) utility for pain relief, up until now, there’s been limited ...
APR 29, 2021
Immunology
A Week for World Immunization
APR 29, 2021
A Week for World Immunization
The World Health Organization (WHO) is calling our attention to World Immunization Week, which comes in the last week of ...
MAY 05, 2021
Immunology
Novel 3D Bio-printed Leukemia Model Shows Potential for Treatment Testing Platform
MAY 05, 2021
Novel 3D Bio-printed Leukemia Model Shows Potential for Treatment Testing Platform
Three-dimensional (3D) printing has become a common technique over the past two decades. Now, the technique has been ado ...
Loading Comments...